Latest Industry Insights

Personalized medicine has the potential to change the cancer patient's journey by predicting how they will respond to different treatments. Technology Networks spoke to Dr. Ofer Sharon, CEO of OncoHost, to find out more!

In this insight, Dr. Zachary Pitluk, vice president of life sciences and healthcare at Paradigm4, gives his view on the major developments that 2022 will hold for informatics in biopharma.

Technological innovations brought in as a result of COVID-19 could produce dramatic changes to how we do science. In this insight, Synthace co-founder Markus Gershater previews a cloud-first future for bioscience.

Technology Networks spoke to Jesse Harris to learn why spreadsheets can be a bottleneck for pharma research and explore how they compare to laboratory informatics tools.

Historically, drug researchers have relied on methods such as focus groups and questionnaires for first-person accounts of patient-reported outcomes. Social media has emerged as a lower cost alternative that is increasingly accepted as a reputable source of information by the research community.

In this interview, Joyce explains the impact her work could have on society, tells us about the benefits that open-source technology has had on her research and highlights the importance of researcher support programs.

Brain-computer interface (BCI) developer Blackrock Neurotech has announced that its MoveAgain BCI has received Breakthrough Device designation from the US Food and Drug Administration (FDA). To find out more, we spoke with Blackrock’s chairman and president, Florian Solzbacher.

In this instalment of Science Futures, we hear from Tijmen Bos, a PhD candidate at the Vrije Universiteit Amsterdam and the University of Amsterdam. Tijmen discusses the impact his research could have on society and how interactions with industry have helped progress his research and prepare him for the end of his PhD.

Thermo Scientific Proteome Discoverer 3.0 software offers a wide range of comprehensive tools for proteomics studies. In this interview, we learn more about the latest version, how it leverages artificial intelligence and what this means for proteomics researchers.

With the advent of electronic health records, it is now possible to access larger, more comprehensive volumes of medical statistics than ever before. In this Insight, Chris Patrick, CEO of cloud provider Nuvodia, explores how this could lead to a medical data revolution.